Sumaiya Sharmeen counsels clients in complex IP litigation matters in the hardware, software, medical device, biotechnology, and pharmaceutical industries.Sumaiya is a member of the firm’s Intellectual Property Group. She applies her degrees in medical biophysics, genetics, and biotechnology to assist clients in intellectual property litigation matters, including trade secrets and patent litigation, preparing infringement and validity analysis, and serving as counsel in fact and expert depositions, motions, hearings, and jury trials. Sumaiya’s work in this area includes proceedings involving gene therapy, monoclonal antibodies, antibody-drug conjugates, manufacturing and purification process of recombinant proteins, and small molecule inhibitors.

Prior to joining the firm, Sumaiya was an attorney in Toronto, where she focused on IP litigation as well as strategic IP counseling. She has litigated before the state and federal trial courts on a wide-range of technologies, including biotechnology, pharmaceuticals, and information technology. In addition to her litigation practice, Sumaiya has advised clients on strategic transactional issues and patent licensing discussions. 

Sumaiya is admitted to practice in California and Ontario (Canada). In addition to her degrees, she earned a certificate in Artificial Intelligence from UC Berkeley Law.